RESOURCES

Archeus Technologies Doses First Patient with ART-101 in Phase 1 Prostate Cancer Study

Archeus Receives FDA Clearance of IND Application for ART-101 for Prostate Cancer

Archeus and WARF Partner to Advance ART-101 into Clinical Development for Prostate Cancer

Archeus Technologies Doses First Patient with ART-101 in Phase 1 Prostate Cancer Study

Archeus Receives FDA Clearance of IND Application for ART-101 for Prostate Cancer

Archeus and WARF Partner to Advance ART-101 into Clinical Development for Prostate Cancer

WANT TO
GET IN TOUCH?

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.